Roger Alvarez

[Roger Alvarez @RogerAlvarezDO]

With our colleagues from @ClevelandClinic we just wrapped up an incredible #PHSummit2025 here in @CleveClinicFL! Thank you to the faculty, sponsors, and attendees. Literally standing room only at times for the dream-team line up of speakers. Can’t wait until next year! #PAH

[Josh Farkas MD 💊 @PulmCrit]

Fresh blog: STRATIFY trial for PE

Peripheral tPA infusion is EQUALLY EFFECTIVE as compared to ultrasound-assisted thrombolysis

Catheter-directed thrombolysis for PE is dead

We can get the same benefits with peripheral tPA infusions (w/o procedural costs & complications)...#1/2

[Amr Abdin @AmrAbdin10]

🚫Harmful Drugs in Heart Failure!💊
A position 🗞️to guide drugs that may cause or exacerbate HF
👉https://t.co/P41ljOTJdg
@JBauersachsMD @SulemanAktaa @JavedButler1 @mvaduganathan @GianluSava @HFA_President @JanBiegus @MagdyAbdelhami7 @NicolasGirerd @WilfriedMullens

[Naftali Kaminski @KaminskiMed]

Is fibroblast proliferation important in pulmonary fibrosis? Finally an answer - great paper by the super team of Christopher Molina,Tatsuya Tsukui, and Dean Sheppard
#זScienceMatters
#CureIPF
https://t.co/SuYKacV3Rj

[Eddy J. Gutierrez, MD @eddyjoemd]

One never forgets the first time they took care of someone with scleroderma renal crisis. If an unfortunate patient presents with this, here's how to manage it. 🎩 tip to the authors.
https://t.co/Sfr6vCn6le

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

This is impressive CV risk reduction with Tirzepatide vs Semaglutide

The fact that we have these incretin therapies available is a game changer. Now we just have to make them accessible and cheaper #GLP1RA #weightloss #CVRisk #CVPrev #cardiotwitter

[Sebastien « Seb » Bonnet @sbonnet2]

Well sotatercept is not only an anti remodeling agent. https://t.co/WSnyxH3Kh8
Bravo to ILH team in Giessen and very proud to be part of this study and much more is coming 😎. @3CPRCouncil @PVRI

[Medthority @Medthority]

What are some of the key takeaways from ESC Congress 2025? Read our highlights article featuring data on VTE risk in specific populations – including pregnant women, people with provoked VTE and concurrent risk factors, and those with renal impairment – on demand with Medthority

[Vincent Rajkumar @VincentRK]

HISTORIC AND PARADIGM CHANGING:

FDA approves daratumumab for high risk smoldering multiple myeloma based on the AQUILA trial— the FIRST ever treatment approved for this indication.

Excellent news and thanks to @JNJInnovMed and the huge worldwide team of investigators for making it happen. @thanosdimop @SagarLonialMD @PlasmaCellPete

[Cleveland Clinic Florida @CleveClinicFL]

"She was on the verge of death," says #Pulmonologist Roger Alvarez, DO, recalling his first meeting with Maria Jennings. She was diagnosed with a rare and potentially fatal disease called chronic thromboembolic pulmonary hypertension (CTEPH).

But after a life-changing surgery, Maria didn’t just survive—she thrived. She underwent a transformative surgery called pulmonary thromboendarterectomy (PTE), which is only offered in a few centers in the world.

“I have strength I didn’t expect to have. I walk more. I don’t get so tired anymore. I am happy. The one who cried before now laughs,” she says.

➡️ Full story: https://t.co/cuaWbUyyyz

[Emergency Medicine News @EMNews]

Check out this must-read throw back article: STEMI Critics Are Right. We're Missing Too Many Heart Attacks by Dr Matt Bivens on why OMI/NOMI matters. @Matt_Bivens

https://t.co/dpZBOcn0hn

[IMCrit @IM_Crit_]

If you have to remember one thing today, this is it:

#foamed #foamcc #meded #MedTwitter

[IMCrit @IM_Crit_]

Friendly reminder:

During an intra-arrest #POCUS, the finding of RV dilation alone is generally insufficient to conclude the presence of a pulmonary embolism & justify the administration of thrombolytics. After a few min of CPR, RV tends to dilate due to

[Vincent Rajkumar @VincentRK]

I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives.

1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.

[Roger Alvarez @RogerAlvarezDO]

@umiamimedicine

[Naftali Kaminski @KaminskiMed]

1/
Finally! Our call on the U.S. medical community & establishment to break their silence on Gaza is out today at the New England Journal of Medicine. This is the first publication describing Gaza's human made humanitarian catastrophe in the Journal!!
https://t.co/jMn4sydlEw

[Josh Farkas MD 💊 @PulmCrit]

@emily_fri @EMHighAK @elewMD @TheShenger @drjgutt @SkylerLentz @sreeja_natesan @MprizzleER @alvarezzzy @kaynani32 @MikePallaci @Chris_McStay @NotSoLilMD @ShehniNadeem @ResusOne @DaveLewMD @davidcarr333 @MRamzyDO @EMinMiami 💯💯 IV dig loading for AF w/ RVR and reduced EF is pretty sweet. it doesn't drop the heart rate immediately, but it often helps & its pretty safe. #zentensivist details here: https://t.co/KP4QvSYMlG @CarrieMahurinMD

[Matt Siuba @msiuba]

Full text is freely available if you want to learn about RV reserve from this extensive work lead by future ⭐️🫀 @PeterOro350724

[Roger Alvarez @RogerAlvarezDO]

@DrRisbo @Acyn Exactly @DrRisbo !

Here’s a piece I wrote that may help those who don’t fully understand the nuances of this argument

https://t.co/tAFDsXinjU

[Roger Alvarez @RogerAlvarezDO]

The truth behind the arguments about immigrants and Medicaid.

#healthpolicy #Medicaid #MedTwitter

https://t.co/MKmFM9g4z4

[Dr sthanu subramanian @drsthanus]

Achieving a Negative Fluid Balance in critically ill patients, a key aspect of fluid management in conditions like sepsis, AKI, and post-operative states.
https://t.co/iBCrFQrY4Y

[NephroPOCUS @NephroP]

Decoding #VExUS: a practical guide for excelling in #POCUS assessment of venous congestion.
- @TaweevatA & team
#FOAMed #Nephpearls
🔗 https://t.co/whfDju3wr8